3 hours Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Recommendation of “Buy” from Analysts MarketBeat
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) has been given a consensus recommendation of “Buy” by the twelve brokerages that are presently covering the firm, Marketbeat.com reports. Ten analysts have rated the stock with a buy recommen…